Lack of covalent binding to rat liver DNA of the hypolipidemic drugs clofibrate and fenofibrate
Authors:
- A. Von DänikenADA. Von Däniken
- W.K. LutzWLW.K. Lutz
- C. SchlatterCSC. Schlatter
- 1 February 1981
- journal article
- research article
- Published by Elsevier in Toxicology Letters
- Vol. 7 (4-5) , 305-310
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Comparative ultrastructural study of rat hepatocytes after treatment with the hypolipidemic agents probucol, clofibrate, and fenofibrateJournal of Toxicology and Environmental Health, 1980
- Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogensNature, 1980
- In vivo covalent binding of organic chemicals to DNA as a quantitative indicator in the process of chemical carcinogenesisMutation Research/Reviews in Genetic Toxicology, 1979
- Tumorigenicity of the hypolipidaemic peroxisome proliferator ethyl-α-p-chlorophenoxyisobutyrate (clofibrate) in ratsBritish Journal of Cancer, 1979
- A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.Heart, 1978
- Time course of the induction of aryl hydrocarbon hydroxylase in rat liver nuclei and microsomes by phenobarbital, 3-methylcholanthrene, 2,3,7,8-tetrachloro-dibenzo-p-dioxin, dieldrin and other inducersBiochemical Pharmacology, 1978
- Hepatic Peroxisome Proliferation: Induction by Two Novel Compounds Structurally Unrelated to ClofibrateScience, 1975
- Hydroxyapatite column chromatography in procedures for isolation of purified DNAAnalytical Biochemistry, 1974
- Drugs and Lipid MetabolismAnnual Review of Pharmacology, 1973
- NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RATNature, 1965